ALCJ Crossject Société Anonyme

EPA · FR · Healthcare · Medical Instruments & Supplies · crossject.com

1.310EUR0.00%Mkt Cap: 85.82M $P/E: —Today

Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. It offers Midazolam for epileptic seizure; Terbutaline for the tr…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company

$49.21BUSDP/E 42.0

MDLN

Medline Inc. - Class A common stock

West Pharmaceutical Services, Inc.

$26.51BUSDP/E 48.2

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation

$14.98BUSDP/E 10.8

BAX

Baxter International Inc.

$12.52BUSD

COO

The Cooper Companies, Inc. - Common Stock

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

Key Statistics

Company

Market Cap85.82M USD

Enterprise Value81.97M USD

Revenue (TTM)148.91K USD

Gross Profit-10.56M USD

Net Income (TTM)-11.27M USD

Revenue/Share0.0030 EUR

Last Price1.310 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees99

CountryFR

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)2.52

PEG—

EV/EBITDA-5.28

EV/Revenue550.45

P/S576.31

P/B-14.09

EPS (TTM)-0.19

EPS (Forward)0.52

52W Range

1.1888% of range2.695

52W High2.695 EUR

52W Low1.188 EUR

Profitability

Gross Margin0.00%

Oper. Margin-10853.28%

EBITDA Margin0.00%

Profit Margin0.00%

ROE212.74%

ROA-34.07%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.90M USD

CapEx (TTM)4.89M USD

FCF Margin—

FCF Yield—

Net Debt6.82M USD

Net Debt/EBITDA-0.44

Balance Sheet

Debt/Equity-4.61

Current Ratio2.96

Quick Ratio2.29

Book Value/Sh-0.09 EUR

Cash/Share0.23 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 EUR

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.0 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)4.400 EUR

Upside (mean)+235.9%

Target Range4.300 EUR – 4.500 EUR

4.300+235.9% to mean4.500

# Analysts2

Ownership

Shares Out.60.27M

Float51.16M

Insiders19.75%

Institutions0.40%

Technical

SMA 501.426 (-8.1%)

SMA 2001.851 (-29.2%)

Beta0.50

S&P 52W Chg14.58%

Avg Vol (30d)204.65K

Avg Vol (10d)168.78K

Technical Indicators

RSI (14)42.3

MACD-0.0328

MACD Signal-0.0403

MACD Hist.+0.0075

BB Upper1.410 EUR

BB Middle1.342 EUR

BB Lower1.274 EUR

BB Width10.12%

ATR (14)0.0726 EUR

Vol Ratio (20d)0.68x